3 STRATEGIES TO CAPTURE NEARLY 100% ACCEPTABLE RESPIRATORY DATA

whitePaper | January 20, 2023

Organizations increasingly recognize that accountability through the implementation of a data privacy management program (DPMP) is essential to operate effectively in the modern digital economy. For many years, the focus of organizations in implementing a DPMP has been mainly to achieve compliance with data protection requirements. Today, many organizations have undergone a shift in understanding and realize that a DPMP is as critical for risk management and compliance as it is for enabling data strategy, building customer trust, winning business, and attracting company investment.

whitePaper | March 12, 2020

Operational Acceptance Testing (OAT) is the penultimate phase of Acceptance Testing in a Software Testing Life cycle and is the last defence line between a software development project and deployment of software on production. FFor decedes, Operational Acceptance has been undermined and misunderstood. Where User Acceptance has been written about and hailed as a final phase in testing before production. User Acceptance is but one side of the coin, Operational Acceptance is the other.

whitePaper | November 25, 2022

We live in a world of exponentially growing data. Within these massive datasets lies incredible potential, but only if users are equipped with tools capable of managing big data at scale and without lag.

whitePaper | November 18, 2022

It’s time to treat data like a product, not an afterthought. A new paradigm has emerged among forward-thinking data teams: treat your data like a product. This may sound easy in theory, but it’s far from it! Product development processes have become incredibly sophisticated, with resources dedicated to reliability, adoption, feature roadmaps, and more.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | November 15, 2019

The potential of artificial intelligence to transform business performance is only now starting to be more widely understood in Financial Services. This is nowhere clearer than in the security domain, where the fusion of big data, advanced analytics and machine learning holds out the promise of startling improvements in cyber defenses through the introduction of Prescriptive Security.